Ingmar Blümcke

Author PubWeight™ 78.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012 2.17
2 Cavernoma-related epilepsy: review and recommendations for management--report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2013 2.00
3 Strumpellin is a novel valosin-containing protein binding partner linking hereditary spastic paraplegia to protein aggregation diseases. Brain 2010 1.93
4 Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Ann Neurol 2002 1.61
5 In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. J Neurochem 2006 1.48
6 Histone deacetylase inhibitors: possible implications for neurodegenerative disorders. Expert Opin Investig Drugs 2008 1.36
7 Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo. J Neurochem 2005 1.35
8 The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 2003 1.26
9 Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum Mol Genet 2008 1.26
10 Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 2004 1.23
11 LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate. Hum Mol Genet 2009 1.21
12 The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease. Stem Cells 2007 1.21
13 Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropathol 2013 1.18
14 Focal cortical dysplasia of Taylor's balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome. Epilepsia 2002 1.15
15 Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI. Acta Neuropathol 2011 1.11
16 Long-term epilepsy-associated tumors. Brain Pathol 2012 1.10
17 Disorganization of the desmin cytoskeleton and mitochondrial dysfunction in plectin-related epidermolysis bullosa simplex with muscular dystrophy. J Neuropathol Exp Neurol 2002 1.09
18 Correlated stage- and subfield-associated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy. Eur J Neurosci 2003 1.08
19 The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis? Epilepsia 2011 1.07
20 Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J Neuropathol Exp Neurol 2009 1.07
21 Low proliferation and differentiation capacities of adult hippocampal stem cells correlate with memory dysfunction in humans. Brain 2010 1.07
22 Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275. Mol Cancer Ther 2006 1.06
23 Malignant glioma-induced neuronal cell death in an organotypic glioma invasion model. Technical note. J Neurosurg 2005 1.03
24 Functional network integration of embryonic stem cell-derived astrocytes in hippocampal slice cultures. Development 2003 1.01
25 Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia type I or II. Epilepsia 2008 1.00
26 Focal Cortical Dysplasias: clinical implication of neuropathological classification systems. Acta Neuropathol 2010 1.00
27 The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion. Mol Cancer Ther 2007 0.99
28 Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling. Acta Neuropathol 2010 0.98
29 The emerging role of DNA methylation in epileptogenesis. Epilepsia 2012 0.95
30 Transient decrease in circulating dendritic cell precursors after acute stroke: potential recruitment into the brain. Clin Sci (Lond) 2009 0.94
31 Spontaneous in vitro transformation of adult neural precursors into stem-like cancer cells. Brain Pathol 2008 0.94
32 Neuropathological spectrum of cortical dysplasia in children with severe focal epilepsies. Acta Neuropathol 2005 0.94
33 Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphoma. J Neuropathol Exp Neurol 2008 0.93
34 EGFR signaling regulates tumor cell migration in craniopharyngiomas. Clin Cancer Res 2011 0.93
35 Analysis of different types of resection for pediatric patients with temporal lobe epilepsy. Neurosurgery 2004 0.92
36 Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas. Brain Pathol 2008 0.91
37 Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells. Brain 2005 0.91
38 Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol 2006 0.91
39 Transcriptional profiling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulation. Neuroreport 2002 0.91
40 CD34-immunoreactive balloon cells in cortical malformations. Acta Neuropathol 2004 0.89
41 Molecular neuropathology of epilepsy-associated glioneuronal malformations. J Neuropathol Exp Neurol 2006 0.88
42 Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas. Acta Neuropathol 2013 0.87
43 Focal cortical dysplasia type IIb in the rolandic cortex: functional reorganization after early surgery documented by passive task functional MRI. Epilepsia 2012 0.86
44 Neuroprotective intervention by interferon-γ blockade prevents CD8+ T cell-mediated dendrite and synapse loss. J Exp Med 2013 0.85
45 MR imaging in the presurgical workup of patients with drug-resistant epilepsy. AJNR Am J Neuroradiol 2004 0.85
46 Good interobserver and intraobserver agreement in the evaluation of the new ILAE classification of focal cortical dysplasias. Epilepsia 2012 0.85
47 Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol 2007 0.84
48 Consequences of a novel caveolin-3 mutation in a large German family. Ann Neurol 2003 0.84
49 Sturge-Weber Syndrome Is Associated with Cortical Dysplasia ILAE Type IIIc and Excessive Hypertrophic Pyramidal Neurons in Brain Resections for Intractable Epilepsy. Brain Pathol 2014 0.84
50 Ex vivo therapy of malignant melanomas transplanted into organotypic brain slice cultures using inhibitors of histone deacetylases. Acta Neuropathol 2006 0.83
51 Intrinsic epileptogenicity of gangliogliomas may be independent from co-occurring focal cortical dysplasia. Epilepsy Res 2011 0.83
52 The overall pathological status of the left hippocampus determines preoperative verbal memory performance in left mesial temporal lobe epilepsy. Hippocampus 2013 0.82
53 Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias. Acta Neuropathol 2006 0.82
54 Hormone receptor expression in craniopharyngiomas: a clinicopathological correlation. Neurosurgery 2010 0.82
55 Abundant hypermethylation of SOCS-1 in clinically silent pituitary adenomas. Acta Neuropathol 2006 0.82
56 Increased frequency of distinct TSC2 allelic variants in focal cortical dysplasias with balloon cells and mineralization. Neuropathology 2009 0.82
57 White matter angiopathy is common in pediatric patients with intractable focal epilepsies. Epilepsia 2008 0.82
58 Cellular pathology of amygdala neurons in human temporal lobe epilepsy. Acta Neuropathol 2003 0.81
59 A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas. Virchows Arch 2010 0.81
60 Absence of immunoglobulin class switch in primary lymphomas of the central nervous system. Am J Pathol 2005 0.81
61 The methylation hypothesis of pharmacoresistance in epilepsy. Epilepsia 2013 0.81
62 The curse of in silico transformation from Palmini's into the ILAE classification system of focal cortical dysplasia: a critical comment. Epilepsia 2013 0.80
63 7T MRI features in control human hippocampus and hippocampal sclerosis: an ex vivo study with histologic correlations. Epilepsia 2014 0.80
64 Axo-somatic inhibition of projection neurons in the lateral nucleus of amygdala in human temporal lobe epilepsy: an ultrastructural study. Exp Brain Res 2007 0.79
65 MEG in frontal lobe epilepsies: localization and postoperative outcome. Epilepsia 2011 0.79
66 PPAR Gamma Activators: Off-Target Against Glioma Cell Migration and Brain Invasion. PPAR Res 2008 0.79
67 Surgery to treat focal frontal lobe epilepsy in adults. Neurosurgery 2002 0.78
68 Clinico-pathological investigations of Rasmussen encephalitis suggest multifocal disease progression and associated focal cortical dysplasia. Epileptic Disord 2013 0.78
69 Increased mitotic and proliferative activity are associated with worse prognosis in papillary tumors of the pineal region. Am J Surg Pathol 2014 0.78
70 Heterotopias, cortical dysplasias and glioneural tumors participate in cognitive processing in patients with temporal lobe epilepsy. Neurosci Lett 2003 0.78
71 Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with long-term epilepsy. Neurosurgery 2004 0.78
72 Drug withdrawal after successful epilepsy surgery: how safe is it? Epilepsy Behav 2009 0.78
73 Mutational and expression analysis of the reelin pathway components CDK5 and doublecortin in gangliogliomas. Acta Neuropathol 2002 0.77
74 Analysis of chromosomal instability in focal cortical dysplasia of Taylor's balloon cell type. Acta Neuropathol 2004 0.77
75 Genetics of epilepsy: epilepsy research foundation workshop report. Epileptic Disord 2007 0.77
76 Hypofractionated stereotactic radiotherapy to the rat hippocampus. Determination of dose response and tolerance. Strahlenther Onkol 2007 0.77
77 Mutational and immunohistochemical analysis of ezrin-, radixin-, moesin (ERM) molecules in epilepsy-associated glioneuronal lesions. Acta Neuropathol 2005 0.76
78 Cellular repair strategies in Parkinson's disease. Ther Adv Neurol Disord 2009 0.76
79 Parry-Romberg syndrome with chronic focal encephalitis: two cases. Clin Neurol Neurosurg 2010 0.76
80 In response to commentary on cavernoma-related epilepsy: review and recommendations for management-report of the surgical task force of the ILAE commission on therapeutic strategies. Epilepsia 2014 0.75
81 Distinct allelic variants of TSC1 and TSC2 in epilepsy-associated cortical malformations without balloon cells. J Neuropathol Exp Neurol 2005 0.75
82 Functional genomics in experimental and human temporal lobe epilepsy: powerful new tools to identify molecular disease mechanisms of hippocampal damage. Prog Brain Res 2002 0.75
83 Risk reduction in dominant temporal lobe epilepsy surgery combining fMRI/DTI maps, neuronavigation and intraoperative 1.5-Tesla MRI. Stereotact Funct Neurosurg 2015 0.75
84 Hippocampal dysplasia with balloon cells: case report and discussion on classification. J Neurol 2014 0.75
85 Neuropathology and epilepsy surgery. Curr Opin Neurol 2022 0.75
86 Papillary tumor of the pineal region with anaplastic small cell component. J Neurooncol 2013 0.75